CeraPedics, Inc. Appoints Glen A. Kashuba as Chief Executive Officer and Jeffrey G. Marx, Ph.D., as President and Chief Operating Officer
5/16/2013 11:07:12 AM
More...
|
CeraPedics, Inc. Adds New Board Member
3/12/2013 6:25:08 AM
More...
|
CeraPedics, Inc. Secures $19 Million Series C Financing
12/12/2012 7:07:31 AM
More...
|
Infuse EU Competitor, CeraPedics, Inc., Working Toward U.S. Clearance for Bone Growth Putty
2/23/2012 8:17:04 AM
More...
|
CeraPedics, Inc.: Prospective, Randomized, Controlled Trial Demonstrates 98% Fusion Rate at 6-Months and 12-Months with i-FACTOR(TM) Biologic Bone Graft and Superiority versus Autograft in Single- and Multi-Level PLIF Spine Surgery
4/12/2011 9:14:27 AM
More...
|
CeraPedics, Inc.: Prospective, Randomized, Controlled Trial Demonstrates 98% Fusion Rate at 6-Months and 12-Months with i-FACTOR(TM) Biologic Bone Graft and Superiority versus Autograft in Single- and Multi-Level PLIF Spine Surgery
4/11/2011 11:02:37 AM
More...
|
CeraPedics, Inc. Receives CE Mark for i-FACTOR Flex Bone Graft
6/30/2010 6:54:56 AM
More...
|
CeraPedics, Inc. Closes $15 Million Series B Financing
4/6/2009 7:33:53 AM
More...
|
CeraPedics, Inc. Raises $15 Million
4/2/2009 6:59:11 AM
More...
|
CeraPedics L.L.C. To Present At Medtech Insight And Windhover Information Inc.'s "In3 Medical Device Summit" Conference, June 21-23, 2006, In San Francisco
6/14/2006 12:36:29 PM
More...
|
|